Загрузка видео...

Не удалось загрузить видео

На главную

GI Pathology 101! For each subsite, we go through path basics – histology, IHC & molecular markers, key features from resection specimen & more. I ask Suntrea Hammer to explain path slides to me like I’m a 5-year-old 😀 Here's Part 1: CRC Full video link & slides below🧵1/4:

13,719 просмотров • 1 год назад •via X (Twitter)

Комментарии: 8

Фото профиля Dr. Nina Niu Sanford
Dr. Nina Niu Sanford1 год назад

YouTube link 2/4:

Фото профиля Dr. Nina Niu Sanford
Dr. Nina Niu Sanford1 год назад

Slides 3/4:

Фото профиля Dr. Nina Niu Sanford
Dr. Nina Niu Sanford1 год назад

Mores slides 4/4. Though much more helpful to listen to Suntrea explain the histo: Other subsites coming soon, let me know any feedback.

Фото профиля Raffaele Di Giacomo, PhD
Raffaele Di Giacomo, PhD1 год назад

Dr. Sanford, your approach to breaking down GI pathology is highly commendable! Understanding histology, IHC, and molecular markers is crucial for accurate diagnosis and treatment planning. A question for @SuntreaHammer: what do you consider the most challenging aspect when explaining molecular markers to a non-specialist? For anyone interested in deepening their knowledge or seeking more detailed reviews on topics like these, I recommend It’s a one-stop platform answering every biomedical question and generating comprehensive reviews. #Medicine #Gastroenterology

Фото профиля Erman Akkus
Erman Akkus1 год назад

❓Adjuvant/perioperative chemotherapy for curative liver metastesectomy of CRC? @myESMO #ESMOGI25 ✅Probably DFS but no OS benefit ✅decision should be individualized ❓ctDNA? 👉 #cancer #oncology #MedX #CRC @OncoAlert @realbowtiedoc

Фото профиля Mario Balsa
Mario Balsa1 год назад

🆕 Final analysis of SURF-RCT/SURF-Cohort for small HCC just dropped in @JCO_ASCO: surgery vs RFA ⚔️ 🎯 5-yr OS: 74.6% (S) vs 70.4% (RFA) 🎯 5-yr RFS: 42.9% (S) vs 42.7% (RFA) 💥 AEs: 3.3% (S) vs 0% (RFA) Sometimes, less is more — and the probe wins again ⚖️ Congrats to @YoKawaguchiUT and all the team! 👏🏼 @OncoAlert #OncoAlertAF @_SEOM @GrupoTTD

Фото профиля Neil Iyengar, MD
Neil Iyengar, MD1 год назад

I am delighted to join @WinshipAtEmory as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!

Фото профиля Stephen V Liu, MD
Stephen V Liu, MD1 год назад

Make plans for #DCLung25 - Saturday, October 4th - Washington DC - a one-day @IASLC endorsed comprehensive lung cancer conference! Dr. Marina Garassino @marinagarassino joins with the latest updates in immunotherapy for NSCLC. Register today!

Похожие видео